Nanotechnology Now - Press Release: Nanomix Announces Award of $500K National Science Foundation Phase IIB Grant

Home > Press > Nanomix Announces Award of $500K National Science Foundation Phase IIB Grant

Abstract:
Nanomix Inc., a leading nanoelectronic detection company commercializing high-value diagnostic and monitoring applications, today announced that it has been awarded a follow-on $500,000 National Science Foundation (NSF) Phase IIB grant. This grant, in addition to the previous grants awarded in 2003 & 2005, brings the total NSF funding awarded to Nanomix for this project to over $1,100,000.

Nanomix Announces Award of $500K National Science Foundation Phase IIB Grant

EMERYVILLE, CA | Posted on February 21st, 2007

The grant award will be used to continue the development and commercialization of Nanomix' Sensation™ nanoelectronic detection platform, through partnership with academia and industry. The platform is the basis for detection applications in the biomolecule, respiratory, and agricultural fields. NSF awards are earned through a peer-reviewed competition, with innovation, educational value and potential economic benefits as criteria.

David Macdonald, Nanomix CEO, said, "We are honored to receive another grant from the National Science Foundation. It further validates the value of our technology and will enable additional progress toward our commercialization goals."

Principal Investigator Dr. Jean-Christophe Gabriel added, "Further development of our nanotube based platform will support our commercialization efforts for multiple applications, all of which offer the critical advantages that we bring to the field of detection: high performance with cost-effective, scalable manufacturing, provided in a small form factor. Random network carbon nanotube field-effect transistors have excellent operating characteristics. The market potential is impressive."

####

About Nanomix
Nanomix is a leading nanoelectronic detection company launching a portfolio of devices based on Sensation™ technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across a broad range of industrial and medical applications where valuable attributes - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California.

For more information, please click here

Contacts:
Nanomix
Bill Perry, 510-428-5300
Vice President of Sales, Marketing
and Business Development

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: